Roche Diagnostics GmbH
Roche Diagnostics GmbH, a subsidiary of the Swiss multinational Roche Holding AG, is a leading player in the global healthcare industry, headquartered in Germany. Established in 1896, Roche Diagnostics has consistently innovated in the fields of in-vitro diagnostics and tissue-based cancer diagnostics, making significant strides in personalised healthcare.
With a strong presence in Europe, North America, and Asia, Roche Diagnostics offers a diverse range of core products and services, including advanced diagnostic instruments, reagents, and software solutions. Their commitment to precision medicine and robust research and development has positioned them as a market leader, recognised for their unique contributions to disease detection and management.
Notable achievements include pioneering advancements in molecular diagnostics and a comprehensive portfolio that supports healthcare professionals in delivering accurate and timely patient care. Roche Diagnostics continues to shape the future of diagnostics, enhancing patient outcomes worldwide.
+53 vs industry average
Roche Diagnostics GmbH’s score of 80 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Roche Diagnostics GmbH?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Roche Diagnostics GmbH yet.
Roche Diagnostics GmbH's reported carbon emissions
Roche Diagnostics GmbH, headquartered in Germany, currently does not have specific emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, any climate commitments or emissions data would be cascaded from the parent company.
Roche Holding AG has made significant strides in addressing climate change, although specific reduction targets or achievements for Roche Diagnostics GmbH are not detailed. The company is involved in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the parent level.
While no absolute emissions figures are provided, Roche Holding AG's commitment to sustainability and climate action reflects a broader industry trend towards reducing carbon footprints and enhancing environmental responsibility. As such, Roche Diagnostics GmbH aligns with these overarching goals, contributing to the global effort to mitigate climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Roche Diagnostics GmbH’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Roche Diagnostics GmbH yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project